Analystreport

Strongbridge Biopharma plc (NASDAQ: SBBP) had its price target raised by analysts at Oppenheimer Holdings Inc. from $5.00 to $6.00. They now have an "outperform" rating on the stock.

Strongbridge Biopharma plc - Ordinary Shares  (SBBP) 
Last strongbridge biopharma plc - ordinary shares earnings: 2/25 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.strongbridgebio.com/investor-overview